The weekly federal-spending brief. One email a Sunday. Free. No tracking.
The BuildoutBeta
Awards

$79,146,088

Department of Health and Human Services·Office of Assistant Secretary for Preparedness and Response

to VEDANTA BIOSCIENCES, INC.

biotechactiveONGOING · MOD OF 2020 CONTRACT
WORK BEGAN2020-09-28·LATEST ACTION2026-04-02·SOURCEUSASPENDING·SOURCE IDCONT_AWD_75A50120C00177_7505_-NONE-_-NONE-
Award description

TO DEVELOP MEDICAL COUNTERMEASURES (MCMS) THAT TREAT ANTIBIOTIC RESISTANT INFECTIONS.

Verbatim from USAspending.gov. Capitalization, abbreviations, and codes are unchanged.

The Buildout's read

What the model surfaced from this award

Confidence: high
In plain English

Develop medical countermeasures to treat antibiotic-resistant infections, an ongoing effort that began in 2020.

Sub-sectors
medical-countermeasuresantibiotic-resistanceinfectious-disease
Why this matters

Antibiotic resistance is a critical public health threat; this 2020–2027 program directly addresses a top CDC priority.

Supply-chain signal

Success could reduce reliance on existing antibiotics and create demand for novel therapeutic manufacturing and distribution infrastructure.

U.S.–China competition angle

China is a major producer of active pharmaceutical ingredients; U.S. development of novel antimicrobial countermeasures reduces dependence on foreign supply chains.

Generated by award_classification v2.1.0 via claude-haiku-4-5-20251001 on 2026-06-01. Cost: $0.002995.

Period of performance
Start
2020-09-28
End
2027-01-31
Status
activein 201 days
Recipient
VEDANTA BIOSCIENCES, INC.
UEI C91JJXT9QND5
View full profile →
Sources

The Buildout does not edit federal records. Any inaccuracy reflects the upstream source; it will update here when corrected there.